Veracyte Inc (US: VCYT) — Healthcare · Share Price, Chart & Market Data
About: Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Diagnostics & Research
Latest price: $34.02 (-0.90%)
VCYTVeracyte Inc
Loading watchlist status…
Trade VCYT now
Veracyte Inc share price
VCYT price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 8:14 pm GMT+0
VCYT price performance
1.522%
5D
13.362%
1M
-19.745%
YTD
7.42%
1Y
VCYT price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 8:14 pm GMT+0
VCYT details
VCYT Market Signals